Skip to content

Comparison of Vital HEAT (vH2) Temperature Management System to Upper-body Forced-air Warming

A Comparison Study of the Vital HEAT (vH2) Temperature Management System to Upper-body Forced-air Warming in Patients Undergoing Open Abdominal Surgery Under General Anesthesia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00815191
Enrollment
73
Registered
2008-12-29
Start date
2008-01-31
Completion date
2008-12-31
Last updated
2016-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery

Keywords

temperature, surgery, heating device

Brief summary

The primary objective of this study is to determine if the intraoperative distal esophageal (core) temperature with vitalHEAT warming is non-inferior to upper-body forced-air warming in patients undergoing open colectomy under general anesthesia. This is a randomized study.

Detailed description

Participants will be randomized into one of two groups. Patients assigned to vitalHEAT warming will have the circulating-water sleeve applied to an arm that will not require intravenous access. An esophageal temperature probe will be inserted and connected to the anesthesia machine monitoring system. Intravenous fluids will be warmed to 40-42°C. As soon as practical after induction, the vitalHEAT warmer will be activated in the appropriate patients and set to high which is 42°C An upper-body forced-air warmer will be positioned over the upper body and exposed arms on patients assigned to forced-air heating. The forced air blower will be set to high which is 43°C and activated as soon as practical, usually after prepping and draping. Patients in both groups will be otherwise draped per surgical routine. Ambient temperature will be maintained near 20°C. Active warming will be maintained until just before extubation. The esophageal temperature probe will be removed, and the patient extubated after emergence from anesthesia. This will conclude the study and subsequent management will be at the discretion of the attending anesthesiologist

Interventions

DEVICEa forced-air warming cover

A forced-air warming cover will be placed on the subject prior to surgery, remain on the subject during surgery and removed after surgery.

DEVICEvital HEAT (vH2) Temperature Management System

The vital HEAT (vH2) Temperature Management System will be placed on the subjects arm prior to surgery. remain on the arm during surgery and removed after surgery.

Sponsors

The Cleveland Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Body-mass index 20-36 kg/m2; * Age 18-75 yrs; * ASA Physical Status 1-3.

Exclusion criteria

* Patient requires an intravenous or arterial catheter distal to the elbow on both arms; * Serious skin lesions on the hands or arms; * History of serious vascular disease in the arms; * Pre-operative fever; * Contraindication to sevoflurane endotracheal anesthesia. * Pre-existing neuropathy

Design outcomes

Primary

MeasureTime frame
Intraoperative Distal Esophageal (Core) Temperatureat 1 hour

Countries

United States

Participant flow

Participants by arm

ArmCount
Warm-water Sleeve
The vital HEAT (vH2) Temperature Management System will be placed on the subject's arm prior to surgery,become activated after anesthesia administration and remain active until surgery ends. vital HEAT (vH2) Temperature Management System: The vital HEAT (vH2) Temperature Management System will be placed on the subjects arm prior to surgery. remain on the arm during surgery and removed after surgery.
37
Forced Air
Subjects assigned the forced-air warming cover will be positioned over the upper body and exposed arms before surgery begins. The forced-air warmer will be removed when surgery is completed. a forced-air warming cover: A forced-air warming cover will be placed on the subject prior to surgery, remain on the subject during surgery and removed after surgery.
34
Total71

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyProtocol Violation11

Baseline characteristics

CharacteristicTotalForced AirWarm-water Sleeve
Age, Continuous49 years
STANDARD_DEVIATION 15
50 years
STANDARD_DEVIATION 15
48 years
STANDARD_DEVIATION 15
Body mass index26.2 kg/m^2
STANDARD_DEVIATION 6
26.3 kg/m^2
STANDARD_DEVIATION 5.3
26.1 kg/m^2
STANDARD_DEVIATION 6.6
Race/Ethnicity, Customized
African American
2 participants1 participants1 participants
Race/Ethnicity, Customized
Unknown
6 participants2 participants4 participants
Race/Ethnicity, Customized
White
63 participants31 participants32 participants
Sex/Gender, Customized
Female
25 participants14 participants11 participants
Sex/Gender, Customized
Male
41 participants18 participants23 participants
Sex/Gender, Customized
Missing
5 participants2 participants3 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 370 / 34
serious
Total, serious adverse events
0 / 370 / 34

Outcome results

Primary

Intraoperative Distal Esophageal (Core) Temperature

Time frame: at 1 hour

ArmMeasureValue (MEAN)Dispersion
Warm-water SleeveIntraoperative Distal Esophageal (Core) Temperature35.96 °CStandard Error 0.081
Forced AirIntraoperative Distal Esophageal (Core) Temperature35.87 °CStandard Error 0.085
p-value: <0.000195% CI: [-0.139, 0.321]ANOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026